ESETT - The Established Status Epilepticus Treatment Trial
Registered with ClinicalTrials.gov: NCT01960075
NIH Project Number: 1U01NS088034-01
Status: Enrollment Closed
The Established Status Epilepticus Treatment Trial (ESETT) is a multicenter, randomized, double-blind, comparative effectiveness study of fos-phenytoin, levetiracetam, and valproic acid in subjects with benzodiazepine-refractory status epilepticus. Patients will be recruited by two national emergency research networks: Neurology Emergency Treatment Trials (NETT) network and Pediatric Emergency Care and Applied Research Network (PECARN). Each network has successfully undertaken a Status Epilepticus treatment trial under exception from informed consent (EFIC) rules. For more information on ESETT click on the Synopsis.
Findings: Click on the NEJM and Lancet icons below to read the ESETT published articles.